These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 18032947

  • 1. Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis.
    Wu J, Rosenbaum E, Begum S, Westra WH.
    Am J Dermatopathol; 2007 Dec; 29(6):534-7. PubMed ID: 18032947
    [Abstract] [Full Text] [Related]

  • 2. Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure.
    Karram S, Novy M, Saroufim M, Loya A, Taraif S, Houreih MA, Rauscher B, Habib RH, Oberkanins C, Khalifeh I.
    Am J Dermatopathol; 2013 Jun; 35(4):412-8. PubMed ID: 23051629
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Benign nodal nevi frequently harbor the activating V600E BRAF mutation.
    Taube JM, Begum S, Shi C, Eshleman JR, Westra WH.
    Am J Surg Pathol; 2009 Apr; 33(4):568-71. PubMed ID: 19033861
    [Abstract] [Full Text] [Related]

  • 6. Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction.
    Turner DJ, Zirvi MA, Barany F, Elenitsas R, Seykora J.
    J Cutan Pathol; 2005 May; 32(5):334-9. PubMed ID: 15811117
    [Abstract] [Full Text] [Related]

  • 7. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
    Indsto JO, Kumar S, Wang L, Crotty KA, Arbuckle SM, Mann GJ.
    J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771
    [Abstract] [Full Text] [Related]

  • 8. High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi.
    Ichii-Nakato N, Takata M, Takayanagi S, Takashima S, Lin J, Murata H, Fujimoto A, Hatta N, Saida T.
    J Invest Dermatol; 2006 Sep; 126(9):2111-8. PubMed ID: 16691193
    [Abstract] [Full Text] [Related]

  • 9. BRAF mutations in melanocytic tumors (nevi and melanomas) from organ transplant recipients.
    Kanitakis J, Baldassini S, Lora V, Euvrard S.
    Eur J Dermatol; 2010 Sep; 20(2):167-71. PubMed ID: 19919912
    [Abstract] [Full Text] [Related]

  • 10. BRAF analysis on a spectrum of melanocytic neoplasms: an epidemiological study across differing UV regions.
    Saroufim M, Habib R, Karram S, Youssef Massad C, Taraif S, Loya A, Houreih MA, Sheikh SS, Amr SS, Satti M, Oberkanins C, Khalifeh I.
    Am J Dermatopathol; 2014 Jan; 36(1):68-73. PubMed ID: 23782679
    [Abstract] [Full Text] [Related]

  • 11. BRAF and NRAS mutations in melanoma and melanocytic nevi.
    Poynter JN, Elder JT, Fullen DR, Nair RP, Soengas MS, Johnson TM, Redman B, Thomas NE, Gruber SB.
    Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
    [Abstract] [Full Text] [Related]

  • 12. RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis.
    Dadzie OE, Yang S, Emley A, Keady M, Bhawan J, Mahalingam M.
    Br J Dermatol; 2009 Feb; 160(2):368-75. PubMed ID: 18945298
    [Abstract] [Full Text] [Related]

  • 13. Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7--challenging the concept of dysplastic nevi as precursor lesions?
    Decarlo K, Yang S, Emley A, Wajapeyee N, Green M, Mahalingam M.
    Hum Pathol; 2010 Jun; 41(6):886-94. PubMed ID: 20233623
    [Abstract] [Full Text] [Related]

  • 14. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
    Salgado CM, Basu D, Nikiforova M, Bauer BS, Johnson D, Rundell V, Grunwaldt LJ, Reyes-Múgica M.
    Pediatr Dev Pathol; 2015 Jun; 18(1):1-9. PubMed ID: 25490715
    [Abstract] [Full Text] [Related]

  • 15. BRAF mutations in conjunctival melanoma.
    Gear H, Williams H, Kemp EG, Roberts F.
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2484-8. PubMed ID: 15277467
    [Abstract] [Full Text] [Related]

  • 16. Genetic alterations in melanocytic tumors.
    Takata M, Saida T.
    J Dermatol Sci; 2006 Jul; 43(1):1-10. PubMed ID: 16750612
    [Abstract] [Full Text] [Related]

  • 17. Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features.
    Kiuru M, Tartar DM, Qi L, Chen D, Yu L, Konia T, McPherson JD, Murphy WJ, Fung MA.
    J Am Acad Dermatol; 2018 Aug; 79(2):221-229. PubMed ID: 29653212
    [Abstract] [Full Text] [Related]

  • 18. Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population.
    Wu D, Wang M, Wang X, Yin N, Song T, Li H, Yu J, Wang DM, Zhao Z.
    Am J Dermatopathol; 2011 Jun; 33(4):341-4. PubMed ID: 21430505
    [Abstract] [Full Text] [Related]

  • 19. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
    McNeal AS, Liu K, Nakhate V, Natale CA, Duperret EK, Capell BC, Dentchev T, Berger SL, Herlyn M, Seykora JT, Ridky TW.
    Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
    [Abstract] [Full Text] [Related]

  • 20. Activation of the mitogen-activated protein kinase pathway in malignant melanoma can occur independently of the BRAF T1799A mutation.
    Yazdi AS, Ghoreschi K, Sander CA, Röcken M.
    Eur J Dermatol; 2010 Oct; 20(5):575-9. PubMed ID: 20605766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.